Literature DB >> 12435513

A variant enterococcal surface protein Esp(fm) in Enterococcus faecium; distribution among food, commensal, medical, and environmental isolates.

Tracy J Eaton1, Michael J Gasson.   

Abstract

Enterococci are increasingly important causes of nosocomial disease. Also, they are associated with food and have a history of use as dairy starter and probiotic cultures. An enterococcal surface protein Esp(fs) is involved the virulence and biofilm-forming capacity of Enterococcus faecalis and recently we demonstrated the presence of a homologue Esp(fm) in E. faecium. Here we describe the complete structure of Esp(fm) and demonstrate that its distribution in E. faecium correlates with disease associated strains from a range of pathological sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435513     DOI: 10.1111/j.1574-6968.2002.tb11446.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  22 in total

Review 1.  Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.

Authors:  I Klare; C Konstabel; S Mueller-Bertling; G Werner; B Strommenger; C Kettlitz; S Borgmann; B Schulte; D Jonas; A Serr; A M Fahr; U Eigner; W Witte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Safety of the surrogate microorganism Enterococcus faecium NRRL B-2354 for use in thermal process validation.

Authors:  Lauren M Kopit; Eun Bae Kim; Roland J Siezen; Linda J Harris; Maria L Marco
Journal:  Appl Environ Microbiol       Date:  2014-01-10       Impact factor: 4.792

3.  Influence of isolate origin and presence of various genes on biofilm formation by Enterococcus faecium.

Authors:  Sam Almohamad; Sudha R Somarajan; Kavindra V Singh; Sreedhar R Nallapareddy; Barbara E Murray
Journal:  FEMS Microbiol Lett       Date:  2014-03-24       Impact factor: 2.742

4.  Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients.

Authors:  M Schmidt-Hieber; I W Blau; S Schwartz; L Uharek; K Weist; T Eckmanns; D Jonas; H Rüden; E Thiel; C Brandt
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

5.  Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis.

Authors:  Preeti M Tendolkar; Arto S Baghdayan; Michael S Gilmore; Nathan Shankar
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China.

Authors:  M Kang; Y Xie; C He; Z X Chen; L Guo; Q Yang; J Y Liu; Y Du; Q S Ou; L L Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-24       Impact factor: 3.267

7.  Virulence factors and in vitro adherence of Enterococcus strains to urinary catheters.

Authors:  E Dworniczek; K Kuzko; E Mróz; Ł Wojciech; R Adamski; B Sobieszczańska; A Seniuk
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

8.  Cytotoxicity of hydrogen peroxide produced by Enterococcus faecium.

Authors:  Terence I Moy; Eleftherios Mylonakis; Stephen B Calderwood; Frederick M Ausubel
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity.

Authors:  Helen Leavis; Janetta Top; Nathan Shankar; Katrine Borgen; Marc Bonten; Jan van Embden; Rob J L Willems
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

10.  Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium.

Authors:  Vanessa Vankerckhoven; Tim Van Autgaerden; Carl Vael; Christine Lammens; Sabine Chapelle; Rosaria Rossi; Daniela Jabes; Herman Goossens
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.